{"id":5886,"date":"2017-04-24T22:16:16","date_gmt":"2017-04-24T22:16:16","guid":{"rendered":"https:\/\/globalhealthintelligence.com\/?p=5886\/"},"modified":"2025-12-01T13:25:54","modified_gmt":"2025-12-01T19:25:54","slug":"korean-latin-american-ties-promoted-at-the-annual-k-pharma-academy-program","status":"publish","type":"post","link":"https:\/\/globalhealthintelligence.com\/pt-br\/news\/korean-latin-american-ties-promoted-at-the-annual-k-pharma-academy-program\/","title":{"rendered":"Korean-Latin American ties promoted at the annual K-Pharma academy program"},"content":{"rendered":"<p>The Korea Health Industry Development Institute (KHIDI) through its annual K-Pharma Academy (KPA) program conducts training for officials from Latin American countries introducing the country\u2019s medical and pharmaceutical industry.<\/p>\n<p>Participants are taught about the innovative tactics and best practices from Korean pharmaceutical and medical equipment manufacturers. The officials are also made aware of Korea\u2019s regulatory systems and the government\u2019s policy supports.<\/p>\n<p>Through this program, the countries intend to improve government-to-government relations in the field of healthcare. Since launch of the program in 2013, officials from 13 Latin American countries have attended it including Argentina, Brazil, Chile, Costa Rica, Columbia, Dominican Republic, Ecuador, Guatemala, Mexico, Nicaragua, Peru, Panama and Uruguay.<\/p>\n<p>It was noted that all related institutions, companies and hospitals were supportive and actively contributed to operating this program smoothly. South Korea is ahead of South America in the development of medicine. Participants were positive about the KPA program.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Korea Health Industry Development Institute (KHIDI) through its annual K-Pharma Academy (KPA) program conducts training for officials from Latin American countries introducing the country\u2019s medical and pharmaceutical industry. <\/p>\n","protected":false},"author":24,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[102],"tags":[77,156,436,437],"class_list":{"0":"post-5886","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-news","7":"tag-healthcare-emerging-markets","8":"tag-healthcare-market-intelligence","9":"tag-k-pharma-academy","10":"tag-korea-health-industry"},"_links":{"self":[{"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/posts\/5886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/comments?post=5886"}],"version-history":[{"count":1,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/posts\/5886\/revisions"}],"predecessor-version":[{"id":28193,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/posts\/5886\/revisions\/28193"}],"wp:attachment":[{"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/media?parent=5886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/categories?post=5886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/globalhealthintelligence.com\/pt-br\/wp-json\/wp\/v2\/tags?post=5886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}